全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Prediction of Outcome in Patients with Guillain Barre Syndrome—An Egyptian Study

DOI: 10.4236/nm.2019.103018, PP. 232-246

Keywords: Guillain-Barre Syndrome (GBS), Nerve Conduction Studies and Electromyography, Demyelinating and Axonal Neuropathy, Hughes Functional Score (F-Score), Plasma Exchange, IVIG

Full-Text   Cite this paper   Add to My Lib

Abstract:

Study Objectives: Guillain-Barre syndrome (GBS) is an acute-onset, monophasic immune-mediated disorder of the peripheral nervous system that often follows an infection. The outcome and prognosis of GBS depend on many factors such as the etiology, clinical features, neurophysiology and immunological parameters. The aim of this study was to assess the factors (clinical, investigatory tools, and therapies) that may affect the outcome of patients with GBS. Patients and methods: this was an analytical observational study that was conducted at Ain Shams university hospitals and Kobri Elkoba Military Hospital including twenty patients with the diagnosis of Guillain Barre Syndrome in the duration from 2016 to 2018. This study included twenty patients with the diagnosis of GBS within two weeks from onset of neurologic symptoms, whom their diagnosis based on the established clinical criteria and verified by investigations. Patients were selected from both genders and aged from 18 to 65 years old. Nerve conduction studies and electromyography were performed within two weeks from admission. Various lines of treatment such as plasma exchange (PE), intravenous immunoglobulins (IVIG) or both were used during the period of admission in hospital. Outcome was assessed by the Hughes functional score (F-score), that was applied to the patients on admission, at end of 4 weeks from onset of neuropathy and at the end of 8 weeks. The final outcome at the end of 8 weeks was classified as follow: Group I: good prognosis (0 - 2) on the Hughes functional score (15 patients) and Group II: poor prognosis (3 - 6) on the Hughes functional score (5 patients). Results: the age of the study population ranged from 18 to 65 years with mean of 36.10 ± 16.08 years. Fifteen (75%) patients were males and 5 (25%) patients were females. There was no statistically significant difference found between poor and good prognosis regarding gender. The most common electrophysiological subtype was demyelinating followed by axonal neuropathy. Most patients (75%) had a good outcome at end of study period. It was found that the different line of treatment administered (plasma exchange or IVIG or both) was not associated with poor or good outcome. The patients who needed mechanical ventilation had significantly poor prognosis. Conclusion: the most common electrophysiological subtype was demyelinating followed by axonal neuropathy. Ascending pattern of weakness was more common than descending pattern in this study population and was not related to prognosis. High Hughes score at admission was associated with

References

[1]  Jacobs, B.C., van den Berg, L., Christine, V., et al. (2017) International Guillain-Barré Syndrome Outcome Study (IGOS): Protocol of a Prospective Observational Cohort Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barrésyndrome. Journal of the Peripheral Nervous System, 22, 68-76.
https://doi.org/10.1111/jns.12209
[2]  Rady, H.I. and Attala, H. (2014) Assessment of New Strategies in the Management of Guillain Barre Syndrome: Cairo University. Journal of Pediatrics & Neonatal Care, 1, Article ID: 00027.
https://doi.org/10.15406/jpnc.2014.01.00027
[3]  Rosen, B.A. (2012) Guillain-Barre Syndrome. Pediatrics in Review, 33, 164-170.
https://doi.org/10.1542/pir.33-4-164
[4]  Sharma, M.B., Chaudhry, R., Tabassum, I., Ahmed, N.H., Sahu, J.K., et al. (2011) The Presence of Mycoplasma Pneumonia Infection and GM1 Ganglioside Antibodies in Guillain-Barre Syndrome. The Journal of Infection in Developing Countries, 5, 459-464.
https://doi.org/10.3855/jidc.1508
[5]  Chiò, A., Cocito, D., Leone, M., Giordana, M.T., Mora, G., Mutani, R. and d’Aosta, V. (2003) Guillain-Barre Syndrome: A Prospective, Population-Based Incidence and Outcome Survey. Neurology, 60, 1146-1150.
https://doi.org/10.1212/01.WNL.0000055091.96905.D0
[6]  Kuitwaard, K., de Gelder, J., Tio-Gillen, A.P., Hop, W.C., van Gelder, T., van Toorenenbergen, A.W., van Doorn, P.A. and Jacobs, B.C. (2009) Pharmacokinetics of Intravenous Immunoglobulin and Outcome in Guillain-Barré Syndrome. Annals of Neurology, 66, 597-603.
https://doi.org/10.1002/ana.21737
[7]  Hughes, R.A., Newsom-Davis, J.M., Perkin, G.D. and Pierce, J.M. (1978) Controlled Trial Prednisolone in Acute Polyneuropathy. The Lancet, 2, 750-753.
https://doi.org/10.1016/S0140-6736(78)92644-2
[8]  Van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B.C. and van Doorn, P.A. (2014) Guillain-Barre Syndrome: Pathogenesis, Diagnosis, Treatment and Prognosis. Nature Reviews Neurology, 10, 469-482.
https://doi.org/10.1038/nrneurol.2014.121
[9]  Esmail, S. (2019) An Overview of Guillain-Barre Syndrome. Neurophysiology and Rehabilitation, 1, 42-46.
https://doi.org/10.33805/2641-8991.113
[10]  Van Koningsveld, R., Steyerberg, E.W., Hughes, R.A., Swan, A.V., van Doorn, P.A. and Jacobs, B.C. (2007) A Clinical Prognostic Scoring System for Guillain-Barre Syndrome. The Lancet Neurology, 6, 589-594.
https://doi.org/10.1016/S1474-4422(07)70130-8
[11]  Munayco, C.V., Soto, M.G., Reyes, M.F., et al. (2019) Epidemiology of Guillain Barre Syndrome in Peru. Revista Peruana de Medicina Experimental y Salud Pública, 36, 10-16.
https://doi.org/10.17843/rpmesp.2019.361.3729
[12]  Harms, M. (2011) Inpatient Management of Guillain-Barre Syndrome. The Neurohospitalist, 1, 78-84.
https://doi.org/10.1177/1941875210396379
[13]  Hadden, R.D., Karch, H., Hartung, H.P., et al. (2011) Preceding Infections, Immune Factors, and Outcome in Guillain-Barre Syndrome. Neurology, 56, 758-765.
https://doi.org/10.1212/WNL.56.6.758
[14]  Zhang, Y., et al. (2018) Prognostic Factors of Guillain-Barré Syndrome: A 111-Case Retrospective Review. Chinese Neurosurgical Journal, 4, 14.
https://doi.org/10.1186/s41016-018-0122-y
[15]  Davidson, A.I., Halstead, S.K., Goodfellow, J.A., Chavada, G., Mallik, A., Overell, J., Lunn, M.P., McConnachie, A., van Doorn, P. and Willison, H.J. (2017) Inhibition of Complement in Guillain-Barre Syndrome: The ICA-GBS Study. Journal of the Peripheral Nervous System, 22, 4-12.
https://doi.org/10.1111/jns.12194
[16]  Kalita, J., Misra, U.K., Goyal, G. and Das, M. (2014) Guillain-Barré Syndrome: Subtypes and Predictors of Outcome from India. Journal of the Peripheral Nervous System, 19, 36-43.
https://doi.org/10.1111/jns5.12050
[17]  Verma, R., Chaudhari, T., Raut, T. and Garg, R. (2013) Clinico-Electrophysiological Profile and Predictors of Functional Outcome in Guillian-Barre Syndrome (GBS). Journal of the Neurological Sciences, 335, 105-111.
https://doi.org/10.1016/j.jns.2013.09.002
[18]  Zaem, Z., Siddiqi, Z. and Zochodone, D.W. (2019) Autonomic Involvement in Guillain-Barre Syndrome: An Update. Clinical Autonomic Research, 3, 289-299.
https://doi.org/10.1007/s10286-018-0542-y
[19]  van Doorn, P. (2013) Diagnosis, Treatment and Prognosis of Guillain-Barré Syndrome (GBS). La Presse Médicale, 42, e193-e201.
https://doi.org/10.1016/j.lpm.2013.02.328
[20]  Christine, V., Pieter, A.D. and Bart, C.J. (2017) Treatment Dilemmas in Guillain-Barré Syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, 88, 346-352.
https://doi.org/10.1136/jnnp-2016-314862
[21]  Nasiri, J., Ghazavi, M., Yaghini, O. and Chaldavi, M. (2018) Clinical Features and Outcome of Guillain-Barré Syndrome. Iranian Journal of Neurology, 12, 49-57.
[22]  Koeppen, S., Kraywinkel, K., Wessendorf, T.E., Ehrenfeld, C.E., et al. (2006) Long-Term Outcome of Guillain-Barre Syndrome. Neurocritical Care, 5, 235-242.
https://doi.org/10.1385/NCC:5:3:235
[23]  Wu, X., Li, C., Zhang, B., Shen, D., Li, T., Liu, K., et al. (2015) Predictors for Mechanical Ventilation and Short-Term Prognosis in Patients with Guillain-Barré Syndrome. Critical Care, 19, 310.
https://doi.org/10.1186/s13054-015-1037-z
[24]  El-Khayat, N.M., Nada, M.A., El-Sayed, H.H., et al. (2018) Factors Associated with Prognosis of Guillian-Barre Syndrome. Journal of Clinical Psychology and Cognitive Science, 2, 29-31.
[25]  Kalita, J., Ranjan, A. and Misra, U.K. (2016) Outcome of Guillain-Barre Syndrome Patients with Respiratory Paralysis. QJM: An International Journal of Medicine, 109, 319-323.
https://doi.org/10.1093/qjmed/hcv190
[26]  Zhahirul, I., Nowshin, P., Gulshan, A., et al. (2019) Risk Factors for Respiratory Failure in Guillain-Barré Syndrome in Bangladesh: A Prospective Study. Annals of Clinical and Translational Neurology, 6, 324-332.
https://doi.org/10.1002/acn3.706
[27]  Umarudee, T., Chanon, K., Suwanna, S., et al. (2015) Clinical Presentations as Predictors of Prolonged Mechanical Ventilation in Guillain-Barré Syndrome in an Institution with Limited Medical Resources. Singapore Medical Journal, 56, 558-561.
https://doi.org/10.11622/smedj.2015152
[28]  Versace, V., Campostrini, S., Tezzon, F., Martignago, S., Kofler, M., Saltuari, L., Sebastianelli, L. and Nardone, R. (2017) Atypical Electrophysiological Findings in a Patient with Acute Motor and Sensory Axonal Neuropathy. Frontiers in Neurology, 8, 594.
https://doi.org/10.3389/fneur.2017.00594
[29]  Mustafa, C. and Ali, R.S. (2019) The Investigation of Guillain-Barre Syndrome and Prognosis. Annals of Medical Research, 26, 763-768.
https://doi.org/10.5455/annalsmedres.2019.02.102
[30]  Hughes, R.A., Swan, A.V., Raphael, J.C., Annane, D., van Koningsveld, R. and van Doorn, P.A. (2007) Immunotherapy for Guillain-Barre Syndrome: A Systematic Review. Brain, 130, 2245-2257.
https://doi.org/10.1093/brain/awm004

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133